HALO (HALOZYME THERAPEUTICS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 3 institutional investors hold HALO (HALOZYME THERAPEUTICS INC) with a combined value of $93.35M across 70,293,000 shares. The largest holder is Point72 Asset Management, L.P. with a position worth $54.24M (0.06% of their portfolio). 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$93.35M
Total Shares Held
70,293,000
Institutional Holders
3
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | $54.24M | 0.06% | +41.1% |
| 2 | CITADEL ADVISORS LLC | $31.47M | 0.00% | +69.2% |
| 3 | BlackRock, Inc. | $7.63M | 0.00% | -17.3% |